News

Ozempic: recommendations for doctors (specialists) and (hospital) pharmacists due to limited availability

There is limited availability of the medicine Ozempic (semaglutide-based solution for subcutaneous injection) due to an acute increase in demand. This limited availability will certainly last until early 2023. Experts from the FAMHP's Unavailability Task Force give recommendations.

Warning against the use of illegal TKTX ointment after applying tattoos

The FAMHP wants to warn consumers in Belgium not to use TKTX ointment, an illegal pain-relieving cream. It is mainly used to alleviate pain when applying a tattoo, permanent make-up ... TKTX ointment is not licensed in Belgium or Europe and therefore no guarantees can be given with regard to the composition, safety, quality or efficiency of this illegal medicine.

HIPRABOVIS IBR MARKER LIVE vaccine against infectious bovine rhinotracheitis: increased incidence of anaphylactic-type reactions in cattle

Since the beginning of 2022, there has been an increase in the incidence of anaphylactic-type reactions in cattle after administration of HIPRABOVIS IBR MARKER LIVE vaccine. The cause has not yet been clearly identified and investigations are ongoing. Veterinarians are asked to report any adverse reactions as soon as possible and, if possible, to provide a complete history of vaccinations and an overview of other veterinary medicinal products previously used.

Call for Belgian laboratories to apply to become the European Union reference laboratory for in vitro diagnostic medical devices

The European Commission has launched a call for laboratories of Member States to apply to become European Union reference laboratories (EURLs) for in vitro diagnostic (IVD) medical devices. The possible designation of such EURLs is provided for in article 100 of the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR).

West Nile virus: launch of weekly overview of affected areas for temporary exclusion of candidate donors in blood establishments or human body material establishments

In order to prevent the spread of West Nile virus through contaminated blood or human body material, candidate donors from areas where autochthonous cases are found must wait before donating. From now until the end of November, the FAMHP will provide weekly updates on the affected areas. This weekly update is based on data from the European Centre for Disease Prevention and Control (ECDC).